在德拉维特综合征模型中,反感性寡核酸恢复了兴奋性,GABA信号和电流密度
Yukun Yuan1, Luis Lopez-Santiago1, Nicholas Denomme1
1Department of Pharmacology, University of Michigan, Ann Arbor, MI 48109, USA.
Brain : a journal of neurology
|October 9, 2023
概括
反感性寡核酸ASO-84通过恢复Nav1.1表达来纠正德拉维特综合征小鼠的内部神经元功能障碍. 这种方法对治疗这种严重的神经障碍有希望.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 德拉维特综合征是一种严重的脑病,与SCN1A基因变异有关,导致Nav1.1通道功能障碍.
- 以前的研究表明,反感性寡核酸STK-001 (ASO-22) 可以增加Nav1.1表达并减少Dravet综合征模型中的发作.
- 在调节SCN1A拼接方面,ASO-22及其代用物ASO-84的精确作用机制仍未完全阐明.
研究的目的:
- 调查ASO-84的作用机制,一种针对SCN1A拼接的新型抗意义寡核酸.
- 评估ASO-84对Dravet综合征小鼠模型中神经元刺激性和GABAergic信号传递的影响.
- 确定ASO-84能否恢复受影响内神经元的正常功能,并支持其治疗潜力.
主要方法:
- 在出生后的第二天,ASO-84或Scn1a+/- Dravet综合征和野生类型小鼠的载体单次脑内静脉注射.
- 在脑切片中对皮质金字塔神经元和帕瓦胺阳性内部神经元的电生理学记录 (出生后的21-25天).
- 测量急性分离的帕瓦胺阳性内部神经元中的电流,并评估GABAergic信号.
主要成果:
- 德拉维特综合征小鼠表现出正常的金字塔神经元刺激性,但双相 (过度刺激,然后过度刺激) 内神经元功能障碍与减少的电流密度.
- 在德拉维特综合征小鼠中,GABAergic对金字塔神经元的信号传递减少,这表明内部神经元功能受损.
- 治疗ASO-84正常化了动作潜力的发射,恢复了的电流密度,并在德拉维特综合征内部神经元中改善了GABAergic信号传递.
结论:
- 在Dravet综合征中,ASO-84可选择性地准并纠正帕瓦胺阳性内部神经元中的兴奋性缺陷.
- 这些发现为ASO-84如何调节SCN1A拼接并恢复Nav1.1功能提供了关键的机械洞察力.
- 对Nav1.1的反感性寡核酸中介上调是一种对德拉维特综合征的有前途的治疗策略.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
430
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
430
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
322
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
322
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Antiepileptic Drugs: Potassium Channel Activators
196
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
196
Antiepileptic Drugs: Glutamate Antagonists
393
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
393
Antiepileptic Drugs: Sodium Channel Blockers
623
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
623


